Masimo Technology Symposium 'Integrating technologies across the care continuum' 17th September, 2019 @ Swissotel – Merchant Court, Singapore nAdvanced technologies in perioperative care - Prof. Adrian Gelb, MBChB, FRCPC, FRCA, University Medical Center, University of California, San Francisco, USA nIntegrating technologies across the care continuum - Mr. Bilal Muhsin – COO, Masimo Corporation, USA nImproving clinical outcomes through advanced patient – a case study - Caroline Stade - RN, MBA – Chief Nursing Officer, UKBB, Basel, Switzerland nTechnology suite walk-through and live demonstration of integrated care - Mr. Bilal Muhsin – COO, Masimo Corporation, USA

Venue : Ballroom A & B, Level 1, Swissotel Merchant Court, Singapore Registration : 6:30 pm Dinner : 6:30 pm - 7:00 pm Symposium : 7:00 pm - 9:00 pm RSVP : www.masimotechnologysymposium.com Masimo Technology Symposium #integratedcare #secureddata #hospitalautomation

Dr. Adrian Gelb, University Medical Center, University of California, San Francisco, USA

Adrian W Gelb MBChB, FRCPC, FRCA is a Professor in the Department of and Perioperative Care, University of California San Francisco (UCSF). Professor Gelb has served as the leader in multiple national and international Anesthesia Societies having been the President of 3 societies - the International Anesthesia Research Society (IARS), the Society for Neuroscience in Anesthesiology and Critical Care (SNACC), and the International Society for Anesthetic Pharmacology (ISAP).

Caroline Stade, RN, MBA – Chief Nursing Officer, UKBB, Basel, Switzerland

Caroline Stade is currently the Chief Nursing Officer at the University Children Hospital Basel, Switzerland. She has held numerous positions and was the designated ‘Expert Nurse’ in Anesthesia and Resuscitation, University Hospital Basel, Switzerland. he has served as an Assessor for the European Foundation of Quality Management (EFQM).

Bilal Muhsin, Chief Operating Officer, Masimo Corporation

Bilal Muhsin is currently the Chief Operating Officer at Masimo. He previously served as Executive Vice President of Engineering, Marketing, and Regulatory Affairs. Since joining the company in 2000, Bilal has held numerous positions within the Masimo Engineering division, helping to develop state-of-the-art methods of measuring several innovative physiological parameters. Under his leadership, Masimo launched multiple new technologies and products.

About Masimo: Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation solutions. Masimo’s mission is to improve patient outcomes and reduce the cost of care. Masimo’s Measure-through Motion and Low ™ oximetry is estimated to be used on more than 100 million patients annually, touching 3 patients every second. Masimo continues to advance its capabilities and has a lot of innovations to its credit such as noninvasive and continuous monitoring of total (SpHb®), connectivity, and automation with innovations like the Root® patient monitoring and connectivity hub and the Patient SafetyNet™ supplemental remote monitoring solution, while expanding into additional measurement areas with SedLine® and O3® brain monitoring and NomoLine® .

MASIMO ASIA PACIFIC PTE.LTD. Masimo Contact : 31 Ubi Road 1, #04-05, Singapore 408694 Seline Ng: 81827198; [email protected] Tel: +65.652 1.6700 (Office), +65.6521.6703 (Direct) Vanessa Tan: 91165033; [email protected] Email: [email protected]